Nidhi Agrawal, MD

Articles by Nidhi Agrawal, MD

Growth Hormone Deficiency in Cancer Survivors

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Experts debate when to start growth hormone after cancer, share pediatric vs adult wait times, and offer tips on long‑acting GH dosing.

Navigating Barriers in Adult GHD Management

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Insurance barriers and missing records complicate adult growth hormone therapy, as experts urge better documentation, transition clinics, and patient-centered care to improve outcomes.

Transitioning GHD Patients from Pediatric to Adult Care — Challenges and Best Practices

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

How to keep growth hormone deficiency patients on track when moving to adult care—cutting waitlists, dropouts, and insurance delays.

Dosing and Managing Long-Acting GH Therapy in Adults — Clinical Factors, Titration, and Side Effects

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Clinicians explain practical weekly growth hormone dosing—weight-based, pen-device rounding, and IGF‑1 checks—plus how puberty, fatigue, and growth velocity guide stopping therapy.

Dosing Long-Acting GH Analogs — Practical Considerations for Pediatric Patients

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Clinicians share practical long‑acting growth hormone dosing tips, from pen‑based rounding to IGF‑1 adjustments, plus when to continue or stop therapy in puberty.

Real-World Registry Data for Long-Acting GH Analogs — SkybriGHt, SkyPASS, ANSWER, and Beyond

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Extension Data for Other Long-Acting GH Analogs

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Weekly lonapegsomatropin shows safe, effective growth hormone therapy, but IGF-1 may run high—learn dosing insights and adult trial outcomes.

Extension Data for Long-Acting GH Analog Lonapegsomatropin in Pediatric and Adult GHD

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Weekly growth hormone cuts injections—learn how it’s designed, who benefits, and key safety unknowns for cancer survivors and diabetes.

Long-Acting Growth Hormone Analogs —Benefits and Safety Considerations

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Clinicians tailor adult growth hormone therapy, titrating doses via IGF-1, age, estrogen effects, side effects, and prioritizing quality-of-life gains over numbers.

Initiating and Managing Growth Hormone Therapy in Adults

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Adult growth hormone therapy starts low and titrates by IGF-1, age, and comorbidities, prioritizing quality-of-life gains and managing estrogen-related resistance.

Initiating Growth Hormone Therapy in Pediatric Patients

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Experts reveal gaps in growth hormone deficiency care: better diagnostics, biomarkers, and training to improve pediatric and adult treatment access.

Unmet Needs in Growth Hormone Deficiency Management

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Learn key signs of pediatric growth hormone deficiency, when they appear, and why timely diagnosis boosts growth, strength, and long-term health.

Growth Hormone Deficiency in Adults — Presentation, Quality of Life, and Diagnostic Challenges

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

How pediatric endocrinologists evaluate poor growth: key labs, IGF-1/IGFBP-3, stimulation testing, and ruling out celiac, Crohn’s, thyroid disease.

Diagnosing Growth Hormone Deficiency in Children — Testing, Tools, and Decision-Making

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Learn how clinicians evaluate poor growth in kids—key labs, IGF‑1 clues, stimulation tests, and ruling out celiac, Crohn’s, thyroid issues.

Recognizing Growth Hormone Deficiency — Symptoms, Presentation, and Quality of Life

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

April 28th 2026

Endocrinology experts compare pediatric and adult growth hormone deficiency—causes, testing, MRI use, and transition care tips to improve outcomes.

Unraveling Growth Hormone Deficiency — Etiology and Prevalence

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

April 28th 2026

Experts compare pediatric vs adult growth hormone deficiency—causes, testing, MRI use, and why retesting matters during transition to adult care.

Nidhi Agrawal, MD

Articles by Nidhi Agrawal, MD

Growth Hormone Deficiency in Cancer Survivors

Navigating Barriers in Adult GHD Management

Transitioning GHD Patients from Pediatric to Adult Care — Challenges and Best Practices

Dosing and Managing Long-Acting GH Therapy in Adults — Clinical Factors, Titration, and Side Effects

Dosing Long-Acting GH Analogs — Practical Considerations for Pediatric Patients

Real-World Registry Data for Long-Acting GH Analogs — SkybriGHt, SkyPASS, ANSWER, and Beyond

Extension Data for Other Long-Acting GH Analogs

Extension Data for Long-Acting GH Analog Lonapegsomatropin in Pediatric and Adult GHD

Long-Acting Growth Hormone Analogs —Benefits and Safety Considerations

Initiating and Managing Growth Hormone Therapy in Adults

Initiating Growth Hormone Therapy in Pediatric Patients

Unmet Needs in Growth Hormone Deficiency Management

Growth Hormone Deficiency in Adults — Presentation, Quality of Life, and Diagnostic Challenges

Diagnosing Growth Hormone Deficiency in Children — Testing, Tools, and Decision-Making

Recognizing Growth Hormone Deficiency — Symptoms, Presentation, and Quality of Life

Unraveling Growth Hormone Deficiency — Etiology and Prevalence

Latest Updated Articles

Trending on HCPLive

ADA 2026 Recap: 5 Key Presentations to Know

How Can Oils, Acupressure, and Supplements Improve Skin Conditions?

Closing Thoughts on ASCVD Management

Teplizumab Receives Accelerated FDA Approval for Stage 3 T1D in Children

Heart Failure Congress 2026 Highlights, with Manreet Kanwar, MD